As of 2025-04-22, the Intrinsic Value of Magenta Therapeutics Inc (MGTA) is -6.33 USD. This MGTA valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.70 USD, the upside of Magenta Therapeutics Inc is -1,004.42%.
Based on its market price of 0.70 USD and our intrinsic valuation, Magenta Therapeutics Inc (MGTA) is overvalued by 1,004.42%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -6.33 - -6.33 | -6.33 | -1,004.42% |
| P/E | (12.40) - (16.45) | (14.02) | -2103.3% |
| DDM - Stable | (6.40) - (18.94) | (12.67) | -1911.6% |
| DDM - Multi | (4.92) - (12.32) | (7.15) | -1121.5% |
| Market Cap (mil) | 42.44 |
| Beta | 2.42 |
| Outstanding shares (mil) | 60.66 |
| Enterprise Value (mil) | -20.19 |
| Market risk premium | 5.00% |
| Cost of Equity | 13.92% |
| Cost of Debt | 5.00% |
| WACC | 8.80% |